Cargando…
Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction
Ischemic heart disease (IHD) is a leading cause of morbidity and mortality worldwide. Growth hormone secretagogues (GHS) have been shown to improve cardiac function in models of IHD. This study determined whether hexarelin (HEX), a synthetic GHS, preserves cardiac function and morphology in a mouse...
Autores principales: | McDonald, Hayley, Peart, Jason, Kurniawan, Nyoman, Galloway, Graham, Royce, Simon, Samuel, Chrishan S., Chen, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949285/ https://www.ncbi.nlm.nih.gov/pubmed/29756411 http://dx.doi.org/10.14814/phy2.13699 |
Ejemplares similares
-
The cardiovascular action of hexarelin
por: Mao, Yuanjie, et al.
Publicado: (2014) -
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury
por: Zambelli, Vanessa, et al.
Publicado: (2021) -
Mitochondria in acute myocardial infarction and cardioprotection
por: Ramachandra, Chrishan J.A., et al.
Publicado: (2020) -
Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin‐induced diabetic rats
por: Zhang, Xinli, et al.
Publicado: (2018) -
Myocardial extracellular volume imaging by CMR quantitatively characterizes myocardial infarction and subclinical myocardial fibrosis
por: Ugander, Martin, et al.
Publicado: (2011)